Skip to main content
JMM Case Reports logoLink to JMM Case Reports
. 2018 May 14;5(6):e005152. doi: 10.1099/jmmcr.0.005152

Non-congenital severe ocular complications of Zika virus infection

Mussaret B Zaidi 1,2, C Gustavo De Moraes 3, Michele Petitto 4, Juan B Yepez 5, Anavaj Sakuntabhai 6,7, Etienne Simon-Loriere 6,7, Matthieu Prot 6,7, Claude Ruffie 5,7, Susan S Kim 8, Rando Allikmets 3, Joseph D Terwilliger 9,10,11,12, Joseph H Lee 10,13, Gladys E Maestre 14,15,16,*
PMCID: PMC6096927  PMID: 30128159

Case summary

In 2016, during a major Zika virus (ZIKV) outbreak in Maracaibo, Venezuela, a 49-year-old woman and an unrelated 4-year-old boy developed bilateral optic neuritis 2–3 weeks after presenting an acute febrile illness characterized by low-grade fever, rash and myalgia [1]. Both patients presented sudden, painless bilateral loss of vision with no corneal or uveal abnormalities. Fundoscopic examination revealed oedema of the optic nerve and optic disc pallor. Optical coherence tomography confirmed bilateral optic nerve head swelling in the case of the adult, but it was not carried out in the child. Automated perimetry performed in the adult revealed bilateral diffuse visual field loss. Magnetic resonance imaging of the brain in both cases was unremarkable. Both patients were diagnosed with bilateral optic neuritis of possible infectious or parainfectious origin. Differential diagnoses that were considered and subsequently discarded included arteritic and non-arteritic ischaemic optic neuropathy, and brain disorders such as multiple sclerosis and brain tumours. Both patients were seropositive for anti-ZIKV IgG and seronegative for anti-ZIKV IgM. In addition, both patients were positive for anti-dengue virus (DENV) IgG for all four DENV serotypes. Management included intravenous methylprednisolone for 3 days, followed by oral prednisolone for 11 days. Although the patients presented a modest improvement in their vision, they continued to have visual impairment after several months of follow-up [1].

Question

Which of the following statements is accurate about non-congenital severe ocular complications of Zika virus (ZIKV) infection?

Answer options

1. They are unique to ZIKV infection and readily distinguishable from complications caused by other flaviviruses.

2. Serious ocular complications are related to the severity of the acute exanthematous illness.

3. The diagnosis can be conclusively established by detecting anti-Zika IgM and/or IgG in the patient’s serum.

4. These complications can lead to permanent visual impairment.

5. There is specific treatment for ocular manifestations caused by ZIKV infection.

Discussion

Correct Answer: 4. These complications can lead to permanent visual impairment.

ZIKV is a mosquito-borne RNA virus belonging to the genus Flavivirus of the family Flaviviridae [2]. The classical clinical picture of ZIKV infection includes fever, exanthema, headache and conjunctivitis. The most common non-congenital, ocular manifestation of ZIKV infection is a self-limiting conjunctivitis. Serious ocular complications have been reported for other arboviruses, such as DENV [3–20], chikungunya virus [21–24], West Nile virus [25–39] and Rift Valley fever virus [9–11, 40] (Table 1). To date, there is no specific ocular lesion that is pathognomonic for ZIKV infection [41–45].

Table 1. Non-congenital ocular complications of common Arbovirus infections.

Type of virus Complication
Zika Uveitis [1, 41, 42]; macular atrophy [46]; chorioretinal scar [47]; chorioretinal macular atrophy [43]
Dengue Maculopathy or neuropathy [3–8]; macular oedema, retinal detachment, retinal vascular occlusion, choroidal changes, optic disk swelling, optic neuritis and neuroretinitis [3–7, 9–20]
Chikungunya Optic neuropathy [21]; conjunctivitis, episcleritis, keratitis, panuveitis, multifocal choroiditis, optic neuritis, neuroretinitis, central retinal artery occlusion, panophthalmitis, lagophthalmos and sixth nerve palsy [22–24]
West Nile Foveal chorioretinal scar, choroidal neovascularization [25]; vitreous haemorrhage secondary to retinal neovascularization, severe ischaemic maculopathy [26]; macular oedema, optic atrophy or retrogeniculate damage; occlusive vasculitis [27–29]; uveitis [30]; vitritis [31]; chorioretinitis [31–35]; multifocal choroiditis [36]; chorioretinal lesions [37]; and optic neuritis [38, 39]
Rift Valley fever Macular or paramacular scarring, retinal vascular occlusion or optic atrophy [9–11, 40]

Non-congenital ocular complications are infrequent, but serious, consequences of ZIKV and other arboviral infections. The complications may appear at the end of the acute febrile illness, but more commonly occur within 2 weeks to 1 month after the onset of symptoms. There is no evidence to suggest that serious ocular complications correlate with the severity of the acute febrile illness. One study, however, found that the white cell count and serum albumin are significant predictors of ocular complications of DENV [46].

Serological testing for arboviral diseases should be performed in all patients with ocular complications and a recent history of acute febrile exanthematous infection, who live, or have travelled to, endemic regions. The presence of IgM to ZIKV strongly suggests that the ocular manifestation is associated with this virus. A causative aetiology, however, can only be established by documenting the presence of the virus in body fluids, either by cell culture or by PCR. It should be noted that other viruses, such as herpes simplex virus and human immunodeficiency virus, can also cause retinal damage and optic neuritis. Furthermore, as in the cases presented here, the diagnosis is complicated by cross-reactivity among flaviviruses, and by the co-circulation of arboviruses.

Most patients with ocular complications of arboviral infections recover completely. Nevertheless, physicians should be aware that a small percentage of patients have permanent damage with long-life visual impairment.

There is no specific or established treatment for optic neuritis caused by any arboviral infection. Systemic steroids may be used to reduce inflammation and resulting ischaemia. Corticosteroids have been used in combination with acyclovir to treat chikungunya-associated optic neuritis, but efficacy has not been proven [47].

Funding information

The authors received no specific grant from any funding agency.

Acknowledgements

We thank Elvira Alvarez and Javier Aracena for their help with literature searches. We also acknowledge the South Texas Diabetes and Obesity Institute for support in preparation of this Case Quiz.

Conflicts of interest

The authors declare that there are no conflicts of interest.

Ethical statement

Our study consists of observations only and no intervention/change to patient care was made.

Footnotes

Abbreviations: DENV, dengue virus; ZIKV, Zika virus.

References

  • 1.de Moraes CG, Pettito M, Yepez JB, Sakuntabhai A, Simon-Loriere E, et al. Optic neuropathy and congenital glaucoma associated with probable Zika virus infection in Venezuelan patients. JMM Case Rep. 2018;5:jmmcr.0.005145. doi: 10.1099/jmmcr.0.005145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Musso D, Gubler DJ. Zika virus. Clin Microbiol Rev. 2016;29:487–524. doi: 10.1128/CMR.00072-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cruz-Villegas V, Berrocal AM, Davis JL. Bilateral choroidal effusions associated with dengue fever. Retina. 2003;23:576–578. doi: 10.1097/00006982-200308000-00031. [DOI] [PubMed] [Google Scholar]
  • 4.Lim WK, Mathur R, Koh A, Yeoh R, Chee SP. Ocular manifestations of dengue fever. Ophthalmology. 2004;111:2057–2064. doi: 10.1016/j.ophtha.2004.03.038. [DOI] [PubMed] [Google Scholar]
  • 5.Bacsal KE, Chee SP, Cheng CL, Flores JV. Dengue-associated maculopathy. Arch Ophthalmol. 2007;125:501–510. doi: 10.1001/archopht.125.4.501. [DOI] [PubMed] [Google Scholar]
  • 6.Beral L, Laurence B, Merle H, Harold M, David T, et al. Ocular complications of dengue fever. Ophthalmology. 2008;115:1100–1101. doi: 10.1016/j.ophtha.2008.02.017. [DOI] [PubMed] [Google Scholar]
  • 7.Teoh SC, Chee CK, Laude A, Goh KY, Barkham T, et al. Optical coherence tomography patterns as predictors of visual outcome in dengue-related maculopathy. Retina. 2010;30:390–398. doi: 10.1097/IAE.0b013e3181bd2fc6. [DOI] [PubMed] [Google Scholar]
  • 8.Chia A, Luu CD, Mathur R, Cheng B, Chee SP. Electrophysiological findings in patients with dengue-related maculopathy. Arch Ophthalmol. 2006;124:1421–1426. doi: 10.1001/archopht.124.10.1421. [DOI] [PubMed] [Google Scholar]
  • 9.Khairallah M, Jelliti B, Jenzeri S. Emergent infectious uveitis. Middle East Afr J Ophthalmol. 2009;16:225––238. doi: 10.4103/0974-9233.58426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Khairallah M, Chee SP, Rathinam SR, Attia S, Nadella V. Novel infectious agents causing uveitis. Int Ophthalmol. 2010;30:465–483. doi: 10.1007/s10792-009-9319-6. [DOI] [PubMed] [Google Scholar]
  • 11.Khairallah M, Yahia SB, Attia S. Arthropod vector-borne uveitis in the developing world. Int Ophthalmol Clin. 2010;50:125–144. doi: 10.1097/IIO.0b013e3181d2cf2e. [DOI] [PubMed] [Google Scholar]
  • 12.Chan DP, Teoh SC, Tan CS, Nah GK, Rajagopalan R, et al. Ophthalmic complications of dengue. Emerg Infect Dis. 2006;12:285–289. doi: 10.3201/eid1202.050274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Siqueira RC, Vitral NP, Campos WR, Oréfice F, de Moraes Figueiredo LT. Ocular manifestations in dengue fever. Ocul Immunol Inflamm. 2004;12:323–327. doi: 10.1080/092739490500345. [DOI] [PubMed] [Google Scholar]
  • 14.Chlebicki MP, Ang B, Barkham T, Laude A. Retinal hemorrhages in 4 patients with dengue fever. Emerg Infect Dis. 2005;11:770–772. doi: 10.3201/eid1105.040992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Loh BK, Bacsal K, Chee SP, Cheng BC, Wong D. Foveolitis associated with dengue fever: a case series. Ophthalmologica. 2008;222:317–320. doi: 10.1159/000144074. [DOI] [PubMed] [Google Scholar]
  • 16.Kanungo S, Shukla D, Kim R. Branch retinal artery occlusion secondary to dengue fever. Indian J Ophthalmol. 2008;56:73–74. doi: 10.4103/0301-4738.37606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.de Amorim Garcia CA, Gomes AH, de Oliveira AG. Bilateral stellar neuroretinitis in a patient with dengue fever. Eye. 2006;20:1382–1383. doi: 10.1038/sj.eye.6702219. [DOI] [PubMed] [Google Scholar]
  • 18.Venkatramani J, Lim WK. Bilateral vitreous haemorrhage associated with dengue fever. Eye. 2006;20:1405–1406. doi: 10.1038/sj.eye.6702259. [DOI] [PubMed] [Google Scholar]
  • 19.Sanjay S, Wagle AM, Au Eong KG. Dengue optic neuropathy. Ophthalmology. 2009;116:170. doi: 10.1016/j.ophtha.2008.08.015. [DOI] [PubMed] [Google Scholar]
  • 20.Tabbara K. Dengue retinochoroiditis. Ann Saudi Med. 2012;32:530–533. doi: 10.5144/0256-4947.2012.30.4.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Mahendradas P, Avadhani K, Shetty R. Chikungunya and the eye: a review. J Ophthalmic Inflamm Infect. 2013;3:35. doi: 10.1186/1869-5760-3-35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Mahendradas P, Ranganna SK, Shetty R, Balu R, Narayana KM, et al. Ocular manifestations associated with chikungunya. Ophthalmology. 2008;115:287–291. doi: 10.1016/j.ophtha.2007.03.085. [DOI] [PubMed] [Google Scholar]
  • 23.Lalitha P, Rathinam S, Banushree K, Maheshkumar S, Vijayakumar R, et al. Ocular involvement associated with an epidemic outbreak of chikungunya virus infection. Am J Ophthalmol. 2007;144:552–556. doi: 10.1016/j.ajo.2007.06.002. [DOI] [PubMed] [Google Scholar]
  • 24.Mittal A, Mittal S, Bharati MJ, Ramakrishnan R, Saravanan S, et al. Optic neuritis associated with chikungunya virus infection in South India. Arch Ophthalmol. 2007;125:1381–1386. doi: 10.1001/archopht.125.10.1381. [DOI] [PubMed] [Google Scholar]
  • 25.Seth RK, Stoessel KM, Adelman RA. Choroidal neovascularization associated with West Nile virus chorioretinitis. Semin Ophthalmol. 2007;22:81–84. doi: 10.1080/08820530701418375. [DOI] [PubMed] [Google Scholar]
  • 26.Khairallah M, Ben Yahia S, Attia S, Zaouali S, Jelliti B, et al. Indocyanine green angiographic features in multifocal chorioretinitis associated with West Nile virus infection. Retina. 2006;26:358–359. doi: 10.1097/00006982-200603000-00019. [DOI] [PubMed] [Google Scholar]
  • 27.Kaiser PK, Lee MS, Martin DA. Occlusive vasculitis in a patient with concomitant West Nile virus infection. Am J Ophthalmol. 2003;136:928–930. doi: 10.1016/S0002-9394(03)00866-3. [DOI] [PubMed] [Google Scholar]
  • 28.Teitelbaum BA, Newman TL, Tresley DJ. Occlusive retinal vasculitis in a patient with West Nile virus. Clin Exp Optom. 2007;90:463–467. doi: 10.1111/j.1444-0938.2007.00140.x. [DOI] [PubMed] [Google Scholar]
  • 29.Gohari AR, Willson RL, Gitter KA. West Nile virus occlusive retinal vasculitis. Retin Cases Brief Rep. 2011;5:209–212. doi: 10.1097/ICB.0b013e3181e18042. [DOI] [PubMed] [Google Scholar]
  • 30.Kuchtey RW, Kosmorsky GS, Martin D, Lee MS. Uveitis associated with West Nile virus infection. Arch Ophthalmol. 2003;121:1648–1649. doi: 10.1001/archopht.121.11.1648. [DOI] [PubMed] [Google Scholar]
  • 31.Bains HS, Jampol LM, Caughron MC, Parnell JR. Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch Ophthalmol. 2003;121:205–207. doi: 10.1001/archopht.121.2.205. [DOI] [PubMed] [Google Scholar]
  • 32.Adelman RA, Membreno JH, Afshari NA, Stoessel KM. West Nile virus chorioretinitis. Retina. 2003;23:100–101. doi: 10.1097/00006982-200302000-00017. [DOI] [PubMed] [Google Scholar]
  • 33.Shaikh S, Trese MT. West Nile virus chorioretinitis. Br J Ophthalmol. 2004;88:1599–1560. doi: 10.1136/bjo.2004.049460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Eidsness RB, Stockl F, Colleaux KM. West Nile chorioretinitis. Can J Ophthalmol. 2005;40:721–724. doi: 10.1016/S0008-4182(05)80088-2. [DOI] [PubMed] [Google Scholar]
  • 35.Myers JP, Leveque TK, Johnson MW. Extensive chorioretinitis and severe vision loss associated with West Nile virus meningoencephalitis. Arch Ophthalmol. 2005;123:1754–1756. doi: 10.1001/archopht.123.12.1754. [DOI] [PubMed] [Google Scholar]
  • 36.Vandenbelt S, Shaikh S, Capone A, Williams GA. Multifocal choroiditis associated with West Nile virus encephalitis. Retina. 2003;23:97–99. doi: 10.1097/00006982-200302000-00016. [DOI] [PubMed] [Google Scholar]
  • 37.Khairallah M, Ben Yahia S, Ladjimi A, Zeghidi H, Ben Romdhane F, et al. Chorioretinal involvement in patients with West Nile virus infection. Ophthalmology. 2004;111:2065–2070. doi: 10.1016/j.ophtha.2004.03.032. [DOI] [PubMed] [Google Scholar]
  • 38.Vaispapir V, Blum A, Soboh S, Ashkenazi H. West Nile virus meningoencephalitis with optic neuritis. Arch Intern Med. 2002;162:606-a–6607. doi: 10.1001/archinte.162.5.606-a. [DOI] [PubMed] [Google Scholar]
  • 39.Gilad R, Lampl Y, Sadeh M, Paul M, Dan M. Optic neuritis complicating West Nile virus meningitis in a young adult. Infection. 2003;31:55–56. doi: 10.1007/s15010-002-3039-4. [DOI] [PubMed] [Google Scholar]
  • 40.Al-Hazmi A, Al-Rajhi AA, Abboud EB, Ayoola EA, Al-Hazmi M, et al. Ocular complications of Rift Valley fever outbreak in Saudi Arabia. Ophthalmology. 2005;112:313–318. doi: 10.1016/j.ophtha.2004.09.018. [DOI] [PubMed] [Google Scholar]
  • 41.Furtado JM, Espósito DL, Klein TM, Teixeira-Pinto T, da Fonseca BA. Uveitis associated with Zika virus infection. N Engl J Med. 2016;375:394–396. doi: 10.1056/NEJMc1603618. [DOI] [PubMed] [Google Scholar]
  • 42.Kodati S, Palmore TN, Spellman FA, Cunningham D, Weistrop B, et al. Bilateral posterior uveitis associated with Zika virus infection. The Lancet. 2017;389:125–126. doi: 10.1016/S0140-6736(16)32518-1. [DOI] [PubMed] [Google Scholar]
  • 43.Parke DW, Almeida DR, Albini TA, Ventura CV, Berrocal AM, et al. Serologically confirmed Zika-related unilateral acute maculopathy in an adult. Ophthalmology. 2016;123:2432–2433. doi: 10.1016/j.ophtha.2016.06.039. [DOI] [PubMed] [Google Scholar]
  • 44.Wong CW, Ng SR, Cheung CM, Wong TY, Mathur R. Zika-related maculopathy. Retin Cases Brief Rep. 2017:doi: 10.1097/ICB.0000000000000552. doi: 10.1097/ICB.0000000000000552. [DOI] [PubMed] [Google Scholar]
  • 45.Marquezan MC, Ventura CV, Sheffield JS, Golden WC, Omiadze R, et al. Ocular effects of Zika virus-a review. Surv Ophthalmol. 2018;63:166–173. doi: 10.1016/j.survophthal.2017.06.001. [DOI] [PubMed] [Google Scholar]
  • 46.Seet RC, Quek AM, Lim EC. Symptoms and risk factors of ocular complications following dengue infection. J Clin Virol. 2007;38:101–105. doi: 10.1016/j.jcv.2006.11.002. [DOI] [PubMed] [Google Scholar]
  • 47.Mahendradas P, Ranganna SK, Shetty R, Balu R, Narayana KM, et al. Ocular manifestations associated with chikungunya. Ophthalmology. 2008;115:287–291. doi: 10.1016/j.ophtha.2007.03.085. [DOI] [PubMed] [Google Scholar]

Articles from JMM Case Reports are provided here courtesy of Microbiology Society

RESOURCES